Dual inhibition of mTORC1 and mTORC2 perturbs cytoskeletal organization and impairs endothelial cell elongation

AUTHOR: Kiyomi Tsuji-Tamura, MinetaroOgawa, JOURNAL: Biochemical and Biophysical Research Communications YEAR: 2018
S-BIO PRODUCT(S): , APPLICATION: Vascular growth, CELL TYPES: Mouse vascular endothelial cell lines, bEnd.3, Subconfluent cultures of bEnd.3

Read The Full Publication

admin2020-06-10T15:50:38-05:00June 10th, 2020|Categories: Publication|

Dual inhibition of mTORC1 and mTORC2 perturbs cytoskeletal organization and impairs endothelial cell elongation

Interesting publication from National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo using ProteoSave, low bind tubes

High-Throughput 3D Tumor Spheroid Screening Method for Cancer Drug Discovery Using Celigo Image Cytometry

Brightfield and Fluorescence Imaging using 3D PrimeSurface® Ultra-Low Attachment Microplates

OZAWA, Masayuki (2015). The N-cadherin cytoplasmic domain confers anchorage-independent growth and the loss of contact inhibition. Scientific Reports. 5: 1-16.

High-Throughput 3D Tumor Spheroid Screening Method for Cancer Drug Discovery Using Celigo Image Cytometry.

Dual inhibition of mTORC1 and mTORC2 perturbs cytoskeletal organization and impairs endothelial cell elongation

Share This Story, Choose Your Platform!

Related Posts

Interesting publication from National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo using ProteoSave, low bind tubes

High-Throughput 3D Tumor Spheroid Screening Method for Cancer Drug Discovery Using Celigo Image Cytometry

Brightfield and Fluorescence Imaging using 3D PrimeSurface® Ultra-Low Attachment Microplates

OZAWA, Masayuki (2015). The N-cadherin cytoplasmic domain confers anchorage-independent growth and the loss of contact inhibition. Scientific Reports. 5: 1-16.

High-Throughput 3D Tumor Spheroid Screening Method for Cancer Drug Discovery Using Celigo Image Cytometry.